_____________ PRST STD US Postage PAID Miami, FL Permit No. 1429

Meetings, Events and Conference Coordinators, Inc. P.O. Box 430376 Miami, FL 33243-0376

11th Annual New Orleans

F

Summer Cancer Meeting

“Making Cancer Research Count for Patients”

O

July 22-24, 2016

O

The Roosevelt Hotel New Orleans New Orleans, LA

11th AnnuAl new OrleAns summer CAnCer meeting

P

R

“Making Cancer Research Count for Patients”

July 22-24, 2016 ROOSEVELT HOTEL New Orleans

Program Chair and Conference Director Edgardo S. Santos, M.D., FACP

Medical Director of Cancer Research Thoracic and Head and Neck Cancer Programs Lynn Cancer Institute/Boca Raton Regional Hospital Associate Professor of Clinical Biomedical Science Charles E. Schmidt College of Medicine Florida Atlantic University

Educational Committee

Pasquale W. Benedetto, M.D. Marcelo Blaya, M.D. Eriberto Marquez, M.D. Bruno Pacheco, M.D. Mark Pegram, M.D. Daniel Petrylak, M.D. Luis E. Raez, M.D., FACP, FCCP Christian Rolfo, M.D. Hope Rugo, M.D. Adrienne M. Vazquez, MSN, ACNP-BC, AOCN Sponsored by: THE MEDICAL EDUCATOR CONSORTIUM

Distinguished Faculty Barbara J. Gilitz, M.D.

Edgardo S. Santos, M.D., FACP

Medical Director of Cancer Research Thoracic and Head and Neck Cancer Programs Lynn Cancer Institute/Boca Raton Regional Hospital Associate Professor of Clinical Biomedical Science Charles E. Schmidt College of Medicine Florida Atlantic University

DISTINGUISHED GUEST FACULTY Sanjiv Agarwala, M.D.

Professor of Medicine Chief, Oncology & Hematology St. Luke’s University Hospital and Temple University Philadelphia, PA

Melisa Alsina, M.D.

Head, Myeloma BMT Program Associate Member Department of Blood and Bone Marrow Transplant H. Lee Moffitt Cancer and Research Center Tampa, FL

Pasquale W. Benedetto, M.D.

Professor of Medicine Director, Hematology/Oncology Fellowship Program University of Miami/Sylvester Comprehensive Cancer Center Miami, FL

Marcelo Blaya, M.D.

Director, Phase I Drug Development Mayo Clinic Scottsdale, AZ

Puneeth Iyengar, M.D., Ph.D.

Director of Clinical Research Lead of Lung Multidisciplinary Committee University of Texas Southwestern Medical Center Dallas, TX

Lorinda A. Coombs, MSN, FNP-BC, AOCNP

P

Assistant Clinical Professor School of Nursing/Community Health Systems University of California San Francisco San Francisco, CA

Hope Rugo, M.D.

Professor of Oncologic Sciences and Senior Member Dept. of Blood and Marrow Transplantation Department of Oncologic Sciences H. Lee Moffitt Cancer Center University of South Florida College of Medicine Tampa, FL

Professor of Medicine Director, Breast Oncology and Clinical Trials Education University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, CA

Rami Komrokji, M.D.

Medical Director of Cancer Research Thoracic and Head and Neck Cancer Programs Lynn Cancer Institute/Boca Raton Regional Hospital Associate Professor of Clinical Biomedical Science Charles E. Schmidt College of Medicine Florida Atlantic University

Affiliate Assistant Professor of Clinical Biomedical Science Charles E. Schmidt College of Medicine Florida Atlantic University Genitourinary Cancer Research Program Lynn Cancer Institute Boca Raton, FL

Janice Lawson, M.D.

Tallahassee Memorial Hospital Physician Partners, Cancer and Hematology Specialists Clinical Assistant Professor, College of Medicine, Florida State University Tallahassee, FL

John Marshall, M.D.

Director, The Ruesch Center for the Cure of GI Cancers Chief, Hematology and Oncology Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington, DC

Reshma Mahtani, D.O.

Hugo F. Fernandez, M.D.

Dido Franceschi, M.D.

Medical Director of Santa Agueda Hospital Department of Medical Oncology Member of SBOC/SLACOM Recife-PE, Brazil

Professor of Surgical Oncology University of Miami/Leonard M. Miller School of Medicine Sylvester Comprehensive Cancer Center Miami, FL

Luis Fayad, M.D.

Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, Clinical Medical Director, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Dual/Joint/Adjunct Appointment, Staff Physician, Lyndon B. Johnson Hospital Houston, TX

Tamer A. Ghanem, M.D. Ph.D.

Director Head and Neck Oncology & Microvascular Surgery Division Otolaryngology Head and Neck Surgery Department Henry Ford Medical Group Detroit, MI

Suresh Ramalingam, M.D.

Mohammed Kharfan-Dabaja, M.D.

Assistant Professor of Medicine, University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, FL

Senior Member, Associate Chief and Clinical Director Department of Blood and Marrow Transplantation Moffitt Cancer Center Tampa, FL

Head of Unit Phase I - Early Clinical Trials Director of Clinical Trial Management Program Oncology Department, University Hospital Antwerp, Belgium

Associate Director, Lung Cancer Program Sarah Cannon Research Institute Nashville, TN

O

Associate Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic, Jacksonville, FL

Christian Rolfo, M.D.

Melissa Johnson, M.D.

R

Gerardo Colon-Otero, M.D.

Director, Memorial Cancer Institute Director, Clinical Oncology Research Memorial Health Care System Clinical Associate Professor of Medicine Herbert Wertheim College of Medicine Florida International University Broward, FL

Professor of Hematology-Oncology Chief of Medical Oncology Georgia Cancer Coalition Distinguished Scholar Emory University School of Medicine Winship Cancer Institute Atlanta, GA

Alan Koletsky, M.D.

Ana Botero, M.D.

Breast Cancer Program Memorial Cancer Institute Memorial Health Cancer System Hollywood, FL

Director of Head & Neck Cancer and Quality Memorial Cancer Institute Clinical Associate Professor of Medicine Herbert Wertheim College of Medicine Florida International University Hollywood, FL

O

Mitesh J. Borad, M.D.

Aurelio Castrellon, M.D.

Brian Hunis, M.D.

Clinical Director, Associate Member, Department of Malignant Hematology H Lee Moffitt Cancer Center & Research Institute Tampa, FL

Memorial Cancer Institute Hollywood, FL

Department of Radiation Oncology Memorial Cancer Institute Memorial Health Care System Hollywood, FL

Luis E. Raez, M.D.

Associate Professor of Medicine, USC Keck School of Medicine Los Angeles, CA

F

PROGRAM CHAIR

Eriberto Marquez, M.D.

Mark Pegram, M.D.

Professor of Medicine Director of the Breast Cancer Program Co-Director of Molecular Therapeutic Program Stanford University Palo Alto, CA

Daniel Petrylak, M.D.

Director, Genitourinary Oncology Research Program Co Director, Signal Transduction Program Yale Comprehensive Cancer Center Yale School of Medicine New Haven, CT

Javier Pinilla Ibarz, M.D.

Associate Member and Director of Immunotherapy Malignant Hematology Department H. Lee Moffitt Cancer Center & Research Institute Tampa, FL

Edgardo S. Santos, M.D., FACP

Tanguy Seiwert, M.D.

Assistant Professor, Department of Medicine Section of Hematology/Oncology Associate Director, Head and Neck Cancer Program Fellow, Institute for Genomics and Systems Chief Editor, Frontiers in Head & Neck Cancer Chicago, IL

Eduardo Sotomayor, M.D.

Director, George Washington University Cancer Center Professor of Medicine, George Washington University School of Medicine & Health Sciences Washington, DC

Tiffany Traina, M.D.

Assistant Attending, Breast Medicine Service Memorial Sloan Kettering Cancer Center Assistant Professor of Medicine, Weill Cornell Medical College New York, NY

Vicente Valero, M.D.

Professor, and Deputy Chairman Breast Medical Oncology Department Clinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic Associate Director, Nellie B. Connally Breast Center The University of Texas M.D., Anderson Cancer Center Houston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCN Memorial Sloan Kettering New York, NY

Gordana Vlahovic, M.D.

Associate Professor of Medicine/Oncology The Preston Robert Tisch Brain Tumor Center at Duke Duke University Medical Center Durham, NC

Jonathan Waxman M.D., FACS, FCCP Medical Director Thoracic Surgery Boca Raton Regional Hospital Affiliate Assistant Professor of Biomedical Sciences Charles E. Schmidt College of Medicine Florida Atlantic University Boca Raton, FL Nerissa Wood, BSN, RN, OCN Clinical Manager, Cancer Center Tulane Medical Center New Orleans, LA

11th AnnuAl new OrleAns summer CAnCer meeting “Making Cancer Research Count for Patients” This is a 3-day national continuing medical education (CME) meeting designed for medical oncologists, hematologists, surgical oncologists, radiation oncologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents and fellows in Hematology/ Oncology as well as other healthcare professionals involved in the management of cancer patients. The 11th Annual New Orleans Summer Cancer Meeting (NOSCM) is a major CME/CE event well established in the Southeast region of the United States. In 2016, the meeting has more innovations. Besides keeping the “Meet-TheProfessor” session which was a tremendous success and well received by the audience, and sometimes only seen in major congresses such as ASCO and ASH, the meeting will also incorporate a surgical session having 3 surgeons (ENT, Thoracic Surgery and GI Oncology surgery), a session special for specialized oncology nurses and also maintenance of certification in oncology for those physicians preparing for the American Board Re-Certification exam. Moreover, based on evaluations from the previous 10 consecutive years, this meeting will provide healthcare professionals taking care of cancer patients with the necessary tools to offer the best quality of care to their patients.

CONFERENCE LEARNING OBJECTIVES Upon completion of “New Orleans Summer Cancer Meeting” attendees will be able to: • Optimize personalized medicine to cancer patients by applying molecular test results from tumor tissue or blood. • Discuss genetics implications in the management of different solid tumor types and malignant hematologic diseases. • Understand the clinical indications, benefit, and potential complications from cyber knife, gamma knife, stereotactic body radiotherapy, and proton therapy in patients affected by different cancer types. • Understand the surgical indications, benefit and risk as well as potential complication from oropharyngeal, lung and pancreas surgery. • Learn novel carcinogenic pathways recently discovered as well as new indications from therapies recently approved by the US FDA for different malignant diagnoses. • Recognize when and to whom apply immunotherapy and how to follow the response in cancer patients treated with this novel modality of therapy. • Diagnose and establish immediate therapy for patients developing grade 3-4 side effects from novel immunotherapy agents, targeted therapies or conventional cytotoxic drugs. • Apply novel therapeutic options in rare cancers including brain tumors and sarcomas.

P

R

O

O

The 11th edition of this national CME/CE program will focus on integrating major advances in basic sciences and how to apply them into the routine clinical practice, and hence, deliver a personalized or individualized medicine to our patients. In 2016, the Educational Committee has included new topics including brain tumor, surgical approaches for oropharyngeal cancer, lung cancer and pancreas carcinoma, and sarcoma. As we know, all progress in oncology will not be possible if we do not have the support from novel technology in radiation therapy. In the 11th NOSCM, discussion on cyber knife, gamma knife and proton therapy will take place. The hematology session in 2016 counts with renowned hematologists who will cover the major hematologic malignancies including bone marrow transplantation as a therapeutic management. The length of the NOSCM allows plenty of time for the audience to discuss in depth different topics in medical oncology and hematology, and share their thoughts with national and international leaders in the field of lung cancer, breast cancer, melanoma, prostate cancer, gastrointestinal carcinomas, kidney carcinoma, ovarian and cervical cancer, head and neck cancer, supportive of care as well as many hematologic malignancies including multiple myeloma, lymphoma, leukemia, and others. The group of guest faculty is represented by expert clinicians and researchers from premier cancer centers in the United States. The most relevant clinical and investigational data presented at major cancer congresses such as the 2015 American Society of Hematology (ASH), the 2016 American Society of Clinical Oncology (ASCO), the 2015 European Society of Medical Oncology, and the 2016 American Association for Cancer Research will be presented and discussed in this forum.

6. Post-evaluation follow-up sent to attendees; this will provide information of the post onference outcomes of those who attended this conference and how it may provide a change in the participants’ professional practice and/or treatment of their patients.

F

DESCRIPTION OF ACTIVITY

Instructional Methods

1. Power Point presentation. 2. Educational material included in the syllabus (and/or flash drive). 3. Active participation between the audience and faculty panel; each session has a “Questions and Answers Session.”

Evaluation and/or Outcome Assessment Plan

1. Onsite evaluation of the program by the attendees. 2. Course Director’s evaluation of the program. 3. Post-conference meeting to review final report and summary. 4. Pre conference test to determine level of knowledge of the attendees prior to CME Activity. 5. Post conference test to determine measured outcomes directly related to the CME Activity.

ACCREDITATION The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT STATEMENT The Medical Educator Consortium designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been submitted to South Central Accreditation Program for approval to award contact hours. South Central Accreditation Program is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

DISCLOSURE The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Conference Agenda FRIDAY, JULY 22 REGISTRATION & VISIT EXHIBITS Breakfast & Learn Symposia (non-CME) Coffee Break and Visit Exhibits Introduction and Educational Overview of “11th Annual New Orleans Summer Cancer Meeting” – Focus on highlights from the 2015 ASH and 2016 ASCO meetings Chair: Edgardo S. Santos, M.D., Lynn Cancer Institute

Radiotherapy and Thrombosis in Oncology 9:00 am - 9:30 am

Cyber Knife, Gamma Knife and SBRT in Oncology Ana Botero, M.D., Memorial Cancer Institute

9:30 am - 10:00 am

Proton Therapy: Who, Where, and How? Puneeth Iyengar, M.D., PhD.

Hypercoagulable Syndromes and New Anticoagulant Therapies Janice Lawson, M.D., Tallahassee Memorial Hospital Physician Partners

10:30 am - 10:40 am

Question and Answer Session Moderator: Edgardo S. Santos, M.D. Lynn Cancer Institute

10:40 am - 11:00 am

Coffee Break & Visit Exhibits

Updates in the Management of Pancreas and Biliary Tract Carcinomas Mitesh Borad, M.D., Mayo Clinic

2:50 pm - 3:15 pm

Brain Tumors: Challenges in Management and Novel Therapeutic Advances Gordana Vlahovic, M.D. Duke University Medical Center

3:15 pm - 3:30pm

Questions and Answers Session Moderator: Marcelo Blaya, M.D.

3:30 pm - 3:45 pm

Head and Neck, Melanoma, Gynecologic Malignancies, and Sarcoma Session 3:45 pm - 4:10 pm

Novel Advances in the Management of Squamous Cell Carcinoma of the Head and Neck Tanguy Seiwert, M.D., University of Chicago

4:10 pm - 4:35 pm

Melanoma: From Immunotherapy to Where Now? Sanjiv Agarwala, M.D., Temple University

4:35 pm - 5:00 pm

Gynecologic Malignancies Gerardo Colon-Otero, M.D., Mayo Clinic

5:00 pm - 5:25 pm

EBUS, VATS and Navigational System: Secure Diagnosis and Enough Tissue for Genetic Testing Jonathan Waxman, M.D., Lynn Cancer Institute

Updates in Soft Tissue Sarcomas. Pasquale W. Benedetto, M.D. University of Miami/Sylvester Cancer Center

5:25 pm - 5:35 pm

Question and Answer Session Moderator: Gerardo Colon-Otero, M.D. Mayo Clinic

R

Special Lecture: Dr. Peter A. Cassileth Memorial Lecture 5:35 pm - 6:05 pm

Targeted Therapy versus Immunotherapy in NSCLC: Better? Equal? Synergistic? Complementary? What is the Right Route? Christian Rolfo, M.D., Antwerp University, Belgium

6:05 pm - 6:15 pm

Question and Answer Session Moderator: Edgardo S. Santos, M.D. Lynn Cancer Institute

Questions and Answers Moderator: Dido Franceschi, M.D.

P

University of Miami/Sylvester Cancer Center

12:40 pm - 1:45 pm 1:45 pm - 2:00 pm

7:00 am - 6:30 pm 7:40 am - 8:30 am 8:30 am - 8:40 am

Coffee Break & Visit Exhibits

Transoral Robotic Surgery for Oropharyngeal Cancer: A Paradigm Shift Tamer Ghanem M.D., PhD, Henry Ford Hospital

12:00 pm – 12:30 pm Pushing the Envelope in the Surgical Management of Pancreas Cancer Dido Franceschi, M.D. University of Miami/Sylvester Cancer Center 12:30 pm - 12:40 pm

2:25 pm - 2:50 pm

O

11:30 am - 12:00 pm

Novel Developments for Metastatic Colorectal Cancer based on Tumor Genotype John Marshall, M.D., Georgetown University

O

10:00 am - 10:30 am

11:00 am - 11:30 am

2:00 pm-02:25 pm

Memorial Cancer Institute

UT Southwestern University

Surgical Oncology Session

Gastrointestinal Cancers and Brain Tumors Session

F

7:00 am - 5:45 pm 7:40 am - 8:40 am 8:40 am - 8:50 am 8:50 am - 9:00 am

Lunch & Learn Symposia (non-CME) Coffee Break & Visit Exhibits

SATURDAY, JULY 23

REGISTRATION & VISIT EXHIBITS Breakfast & Learn Symposia (non-CME) Coffee Break & Visit Exhibit

9:55 am - 10:20 am

How to Optimize the Management of HER2+ Breast Cancer Patients: What’s new? Hope Rugo, M.D. University of California San Francisco

10:20 am - 10:55 am

How do I Treat Triple Negative Breast Cancer: Actual and Future Challenges? Tiffany Traina, M.D. Memorial Sloan-Kettering Cancer Center

Breast Cancer Session 8:40 am - 9:05 am

Gene Expression Profile and Genomics: Moving forward the Bar for Breast Cancer Therapy Development Mark Pegram, M.D., Stanford University

9:05 am - 9:30 am

Novel Pathways and Targets for Metastatic Breast Cancer (excluding Triple Negative Breast Cancer) Vicente Valero, M.D., M.D. Anderson Cancer Center

10:55 am - 11:05 am

Neoadjuvant and Adjuvant Therapies in Early Stage Breast Cancer Patients. Reshma Mahtani, D.O. University of Miami/Sylvester Cancer Center

Question and Answer Session Moderator: Aurelio Castrellon, M.D. Memorial Cancer Institute

11:05 am-11:20 am

Coffee Break & Visit Exhibits

9:30 am - 9:55 am

SATURDAY, JULY 23 continued Meet The Experts (Round Table Discussion) 11:20 am-12:20 pm

Discussion on Challenges and Controversies in the Managment of Different Solid Tumor Types (Case Oriented): Chairs: Marcelo Blaya, M.D. & Brian Hunis, M.D. Table 1: Sarcoma (Dr. Pasquale W. Benedetto) Table 2: Prostate Cancer (Dr. Daniel Petrylak) Table 3: Renal Cell Carcinoma (Dr. Alan Koletsksy) Table 4: Breast Cancer (Drs. Mark Pegram and Hope Rugo) Table 5: Lung Cancer (Drs. Melissa Johnson & Barbara Gilitz) Table 6: Colorectal Cancer (Dr. Mitesh Borad and John Marshall) Table 7: Gynecologic Malignancies (Dr. Colon-Otero) Table 8: Brain Tumors (Dr. Gordana Vhalovic) Table 9: Head and Neck Cancer (Drs. Brian Hunis and Luis E. Raez)

12:25 pm - 1:25 pm 1:25 pm - 1:35 pm

Lunch & Learn Symposia (non-CME) Coffee Break & Visit Exhibits

3:35 pm - 4:00 pm

Renal Cell Carcinoma, From Antiangiogenesis to Immunotherapy: Where Are We Moving Toward? Alan Koletsky, M.D. Lynn Cancer Institute

4:00 pm - 4:10 pm

Question and Answer Session Moderator: Eriberto Marquez, M.D. SEQUIPE/IMIP and Santa Agueda Hospital Recife, Brasil Coffee Break & Visit Exhibits

F

Moderators: Edgardo S. Santos, M.D. Gerardo Colon-Otero, M.D. Reshma Mahtani, M.D. Luis E. Raez, M.D.

Supportive Care in Oncology (Session for Nurses)

4:25 pm - 5:00 pm

Immunotherapy in Lung Cancer: Challenges in Assessment and Management of Complications Luis E. Raez, M.D., Memorial Cancer Institute

5:00 pm - 5:25 pm

Novel Targeted Pathways in Non-Squamous NSCLC: EGFR, ALK, ROS-1, and more Suresh Ramalingam, M.D., Emory University

5:25 pm - 5:50 pm

Squamous NSCLC: Where Are We Now and Challenges in Therapeutic Development Edgardo S. Santos, M.D. Lynn Cancer Institute

5:50 pm - 6:15 pm

Small Cell Lung Cancer: Updates and New Horizons Melissa Johnson, M.D. Tennessee Oncology Sarah Canon Research Institute

6:15 pm - 6:40 pm

Novel Carcinogenic Pathways and Novel Therapies for Metastatic NSCLC Barbara Gilitz, M.D. University of South California Question and Answer Session Moderator: Brian Hunis, M.D. Thoracic Oncology Memorial Cancer Institute

O

Novel Oral Anticoagulant Use in Patients with Cancer Lorinda A. Coombs, MSN, FNP-BC, AOCNP University of California San Francisco Management of Nausea/Vomiting from Highly Emetogenic Chemotherapy Regimens Nerissa Wood, BSN, RN, OCN Tulane University Health Sciences Center

R

Management of Autoimmune Side Effects from Novel Immunotherapy Agents including checkpoint Inhibitors Adrienne M. Vazquez, MSN, ACNP-BC, AOCN Memorial Sloan-Kettering Cancer Center Questions and Answers Moderator: Adrienne M.Vazquez, MSN, ACNP-BC, AOCN Memorial Sloan-Kettering Cancer Center

P

2:50 pm - 3:00 pm

Prostate Cancer: Where Are We Now and Where Are We Moving to? Is it immunotherapy, Single Targeted Agent or Combinations? Daniel Petrylak, M.D. Yale University

O

MOC ~ Maintenance Of Certification ~ Oncology (Session for Physicians)

2:25 pm - 2:50 pm

3:10 pm - 3:35 pm

Thoracic Oncology Session

1:35 pm - 3:00 pm

2:00 pm - 2:25 pm

7:00 am - 12:00 pm 7:40 am - 8:25 am 8:25 am - 8:35 am

Coffee Break & Visit Exhibits

Genitourinary and Gynecology Session

4:10 pm - 4:25 pm

CONCURRENT SESSIONS

1:35 pm - 2:00 pm

3:00 pm - 3:10 pm

6:40 pm - 6:50 pm

SUNDAY, JULY 24

REGISTRATION & VISIT EXHIBITS Breakfast & Learn Symposia (non-CME) Coffee Break & Visit Exhibit

Hematology Session 8:35 am - 9:00 am

Updates in Chronic Leukemia: CLL and CML Javier Pinilla Ibarz, M.D. H. Lee Moffitt Cancer Center

9:00 am - 9:25 am

B-Cell Non-Hodgkin’s Lymphomas: Genomics and Targeted Therapies. Eduardo Sotomayor, M.D. George Washington University

10:15 am - 10:25 am

Question and Answer Session Moderator: Eduardo Sotomayor, M.D. George Washington University

10:25 am - 10:40 am

Coffee Break & Visit Exhibits

10:40 am - 11:05 am

Multiple Myeloma: Induction, Consolidation and Maintenance Therapy Melisa Alsina, M.D., H. Lee Moffitt Cancer Center

11:05 am - 11:30 am

T-cell Lymphoma: Novel advances in 2016 Luis Fayad, M.D., M.D. Anderson Cancer Center

11:30 am - 11:55 am

Myelodysplasia: How to manage Elderly Patients with High Risk MDS Rami Komrokji, M.D., H. Lee Moffitt Cancer Center

9:25 am - 9:50 am

Updates in Acute Leukemia: AML and ALL Hugo Fernandez, M.D. H. Lee Moffitt Cancer Center

11:55 am - 12:05 pm

9:50 am - 10:15 am

Hematopoietic cell transplantation in lymphoid malignancies Mohammed Kharfan-Dabaja, M.D. H. Lee Moffitt Cancer Center

Questions and Answers Session Moderator: Edgardo S. Santos, M.D. Lynn Cancer Institute

12:05 pm - 12:10 pm

Closing Remarks & Conference Outcomes Complete and return conference evaluation forms Chair: Edgardo S. Santos, M.D. Lynn Cancer Institute

REGISTRATION Fees:

HOTEL INFORMATION The Roosevelt Hotel New Orleans

$90 – Nurses/Physician Assistants/Fellows/ Residents/Office Staff $225 – Physicians $300 – Industry Professionals $ 75 – MOC Session (Physician only)

123 Baronne Street New Orleans, LA 70112 Website: www.therooseveltneworleans.com RESERVATIONS: 1-800-925-3673 ONLINE RESERVATIONS: www.therooseveltneworleans.com and enter the group code “SUM” on the reservations page.

Registration fee includes admission to Friday, Saturday & Sunday scientific presentations and handout materials. Refunds must be provided in writing prior by June 22nd, 2016. After June 22nd, 2016, No Refunds will be provided.

The Roosevelt Hotel provides travelers with a unique haven in the center of the city, blending its rich history and timeless service with the latest amenities. Adjacent to the famed French Quarter, one block from Bourbon St., the Roosevelt is just moments from the Canal Streetcar Line, the Louisiana Super Dome, and Mississippi River attractions.

Register online at www.meccinc.com

The Roosevelt is offering special rates during this conference of $155 for King Bed Deluxe accommodation or $165 for a 2 Queen Bed Deluxe Room or $175 for a King Bed Superior Room plus tax. European plan (no meals). The cutoff date to make reservations is June 21, 2016; after this date, reservations are subject to hotel availability. Reservations must be guaranteed by one night’s deposit with a major credit card.

F

For more information contact:

CONFERENCE MANAGEMENT MECC (Meetings Events & Conference Coordinators, Inc) 1550 S. Dixie Highway Suite 202 Coral Gables, FL 33146 Telephone 305/663-1628 Office Fax 305/675-2718

O

Reservations may be made by calling RESERVATIONS 1-800-925-3673. When making your reservations please identify yourself as attending New Orleans Summer Cancer Meeting, Group Code “SUM” to ensure you receive the group rate.

O

Or visit our website at www.meccinc.com

REGISTRATION FORM

R

11th AnnuAl new ORegister rleAns summer CAnCer meeting online at www.meccinc.com Name __________________________________________________________________________ Degree ____________________________

P

Address ___________________________________________________________________________________________________________ City _________________________________________________ State ______________________ Zip ______________________________ Telephone (_____)_____________________________________________ Fax (_____) ____________________________________________ Email address ______________________________________________________________________________________________________ Specialty __________________________________________________________________________________________________________ Type of Practice:

o Private

o Academic

o Hospital

o Resident/Fellow

Registration fee: $ 90 - Nurses/Fellows/Residents/Physician Assistants/Office Staff $ 225 - Physicians $ 300 - Industry Professionals $ 75 - MOC Session (Physician Only) I authorize MECC to charge my credit card i/a/o $____________ for registration of this course using the following credit card. Name on Card ________________________________________________________________ Exp. Date _____________________________ Card number _______________________________________________________________________________________________________ Authorized signer ___________________________________________________________________________________________________ If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than June 22nd, 2016 via email at [email protected].